arrow_back Trending Legislation
Share share

Support for Pediatric Disease Research and Young Scientists Development.

This act aims to accelerate pediatric disease research by funding promising scientists. This will help children receive new, effective therapies faster, and support young researchers in their scientific careers. It's a step towards better healthcare for the youngest.
Key points
New funding for pediatric disease research, including cancer, rare diseases, and children's mental health.
Support for early-career scientists, including physician-scientists, to conduct important research.
Establishment of a consortium to coordinate pediatric research for better collaboration and efficiency.
Prioritization of research involving historically underrepresented populations, such as women and racial minorities.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Pediatricians Accelerate Childhood Therapies Act of 2023
Print number: HR 4714
Sponsor: Rep. Joyce, John [R-PA-13]
Process start date: 2023-07-18
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Support for Pediatric Disease Research and Young Scientists Development.

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 4714.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-07-18.

What are the main provisions?

Key points include:

  • New funding for pediatric disease research, including cancer, rare diseases, and children's mental health.
  • Support for early-career scientists, including physician-scientists, to conduct important research.
  • Establishment of a consortium to coordinate pediatric research for better collaboration and efficiency.
  • Prioritization of research involving historically underrepresented populations, such as women and racial minorities.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Joyce, John [R-PA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 4714

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health